Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,550 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular genetics and biomarkers of polyglutamine diseases.
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Tanaka F, Adachi H, Sobue G. Katsuno M, et al. Among authors: kawashima m. Curr Mol Med. 2008 May;8(3):221-34. doi: 10.2174/156652408784221298. Curr Mol Med. 2008. PMID: 18473821 Review.
Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
Banno H, Katsuno M, Suzuki K, Takeuchi Y, Kawashima M, Suga N, Takamori M, Ito M, Nakamura T, Matsuo K, Yamada S, Oki Y, Adachi H, Minamiyama M, Waza M, Atsuta N, Watanabe H, Fujimoto Y, Nakashima T, Tanaka F, Doyu M, Sobue G. Banno H, et al. Among authors: kawashima m. Ann Neurol. 2009 Feb;65(2):140-50. doi: 10.1002/ana.21540. Ann Neurol. 2009. PMID: 19259967 Clinical Trial.
The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy.
Suzuki K, Katsuno M, Banno H, Takeuchi Y, Kawashima M, Suga N, Hashizume A, Hama T, Uchida K, Yamashita F, Nakamura T, Hirayama M, Tanaka F, Sobue G. Suzuki K, et al. Among authors: kawashima m. J Neurol Neurosurg Psychiatry. 2010 May;81(5):567-71. doi: 10.1136/jnnp.2009.190462. Epub 2009 Dec 3. J Neurol Neurosurg Psychiatry. 2010. PMID: 19965845
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial.
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I, Sasaki H, Aoki M, Morita M, Nakano I, Kanai K, Ito S, Ishikawa K, Mizusawa H, Yamamoto T, Tsuji S, Hasegawa K, Shimohata T, Nishizawa M, Miyajima H, Kanda F, Watanabe Y, Nakashima K, Tsujino A, Yamashita T, Uchino M, Fujimoto Y, Tanaka F, Sobue G; Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group. Katsuno M, et al. Among authors: kawashima m. Lancet Neurol. 2010 Sep;9(9):875-84. doi: 10.1016/S1474-4422(10)70182-4. Epub 2010 Aug 4. Lancet Neurol. 2010. PMID: 20691641 Clinical Trial.
Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials.
Hashizume A, Katsuno M, Suzuki K, Banno H, Takeuchi Y, Kawashima M, Suga N, Mano T, Araki A, Hijikata Y, Hirakawa A, Sobue G; JASMITT study group. Hashizume A, et al. Among authors: kawashima m. J Neurol. 2019 May;266(5):1211-1221. doi: 10.1007/s00415-019-09251-x. Epub 2019 Mar 7. J Neurol. 2019. PMID: 30847645
1,550 results